ITMI20100196A1 - POLYMERS AND COMPOSITIONS FOR THE PREVENTION OR TREATMENT OF MUCOSAL DETOXATION FROM ELEMENTARY AND BIVALENT MERCURY - Google Patents
POLYMERS AND COMPOSITIONS FOR THE PREVENTION OR TREATMENT OF MUCOSAL DETOXATION FROM ELEMENTARY AND BIVALENT MERCURY Download PDFInfo
- Publication number
- ITMI20100196A1 ITMI20100196A1 IT000196A ITMI20100196A ITMI20100196A1 IT MI20100196 A1 ITMI20100196 A1 IT MI20100196A1 IT 000196 A IT000196 A IT 000196A IT MI20100196 A ITMI20100196 A IT MI20100196A IT MI20100196 A1 ITMI20100196 A1 IT MI20100196A1
- Authority
- IT
- Italy
- Prior art keywords
- polymer
- mercury
- polymers
- elemental
- composition
- Prior art date
Links
- 229920000642 polymer Polymers 0.000 title claims description 102
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 title claims description 50
- 229910052753 mercury Inorganic materials 0.000 title claims description 41
- 239000000203 mixture Substances 0.000 title claims description 41
- 230000002265 prevention Effects 0.000 title description 9
- 239000000499 gel Substances 0.000 claims description 29
- 229920002807 Thiomer Polymers 0.000 claims description 24
- 229920005989 resin Polymers 0.000 claims description 20
- 239000011347 resin Substances 0.000 claims description 20
- 238000001784 detoxification Methods 0.000 claims description 13
- 229910000497 Amalgam Inorganic materials 0.000 claims description 11
- 229920001661 Chitosan Polymers 0.000 claims description 11
- -1 argentite Inorganic materials 0.000 claims description 10
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 9
- 238000006243 chemical reaction Methods 0.000 claims description 9
- 239000000243 solution Substances 0.000 claims description 8
- 239000000606 toothpaste Substances 0.000 claims description 8
- 229940034610 toothpaste Drugs 0.000 claims description 8
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 7
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 7
- 125000003396 thiol group Chemical group [H]S* 0.000 claims description 7
- 150000007944 thiolates Chemical class 0.000 claims description 7
- 229910052751 metal Inorganic materials 0.000 claims description 6
- 239000002184 metal Substances 0.000 claims description 6
- 239000002324 mouth wash Substances 0.000 claims description 6
- 229940051866 mouthwash Drugs 0.000 claims description 6
- 239000000725 suspension Substances 0.000 claims description 6
- 208000008763 Mercury poisoning Diseases 0.000 claims description 5
- 229920002873 Polyethylenimine Polymers 0.000 claims description 5
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 5
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims description 5
- 239000007800 oxidant agent Substances 0.000 claims description 5
- 229910052709 silver Inorganic materials 0.000 claims description 5
- 239000004332 silver Substances 0.000 claims description 5
- 125000000446 sulfanediyl group Chemical group *S* 0.000 claims description 5
- 229910052725 zinc Inorganic materials 0.000 claims description 5
- 239000011701 zinc Substances 0.000 claims description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 4
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 claims description 4
- 206010027439 Metal poisoning Diseases 0.000 claims description 4
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 4
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 4
- 229940112822 chewing gum Drugs 0.000 claims description 4
- 235000015218 chewing gum Nutrition 0.000 claims description 4
- 229910052802 copper Inorganic materials 0.000 claims description 4
- 239000010949 copper Substances 0.000 claims description 4
- 235000013305 food Nutrition 0.000 claims description 4
- 125000000524 functional group Chemical group 0.000 claims description 4
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 4
- 229910052737 gold Inorganic materials 0.000 claims description 4
- 239000010931 gold Substances 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 4
- 230000009885 systemic effect Effects 0.000 claims description 4
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 3
- 229910052782 aluminium Inorganic materials 0.000 claims description 3
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 3
- 230000006378 damage Effects 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 3
- 229920000592 inorganic polymer Polymers 0.000 claims description 3
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 claims description 3
- 210000000214 mouth Anatomy 0.000 claims description 3
- 231100000252 nontoxic Toxicity 0.000 claims description 3
- 230000003000 nontoxic effect Effects 0.000 claims description 3
- 229910052683 pyrite Inorganic materials 0.000 claims description 3
- NIFIFKQPDTWWGU-UHFFFAOYSA-N pyrite Chemical compound [Fe+2].[S-][S-] NIFIFKQPDTWWGU-UHFFFAOYSA-N 0.000 claims description 3
- 239000011028 pyrite Substances 0.000 claims description 3
- 239000000377 silicon dioxide Substances 0.000 claims description 3
- 229910052950 sphalerite Inorganic materials 0.000 claims description 3
- 229910052717 sulfur Inorganic materials 0.000 claims description 3
- 239000011593 sulfur Substances 0.000 claims description 3
- RSPCKAHMRANGJZ-UHFFFAOYSA-N thiohydroxylamine Chemical compound SN RSPCKAHMRANGJZ-UHFFFAOYSA-N 0.000 claims description 3
- 150000003573 thiols Chemical class 0.000 claims description 3
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims description 3
- 230000002496 gastric effect Effects 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 229910052951 chalcopyrite Inorganic materials 0.000 claims 1
- DVRDHUBQLOKMHZ-UHFFFAOYSA-N chalcopyrite Chemical compound [S-2].[S-2].[Fe+2].[Cu+2] DVRDHUBQLOKMHZ-UHFFFAOYSA-N 0.000 claims 1
- 239000006185 dispersion Substances 0.000 claims 1
- 239000000839 emulsion Substances 0.000 claims 1
- 239000003517 fume Substances 0.000 claims 1
- 239000007902 hard capsule Substances 0.000 claims 1
- 229910052945 inorganic sulfide Inorganic materials 0.000 claims 1
- 229910052976 metal sulfide Inorganic materials 0.000 claims 1
- 239000003094 microcapsule Substances 0.000 claims 1
- 239000008188 pellet Substances 0.000 claims 1
- 239000006187 pill Substances 0.000 claims 1
- 239000007901 soft capsule Substances 0.000 claims 1
- 239000007787 solid Substances 0.000 claims 1
- 239000006188 syrup Substances 0.000 claims 1
- 235000020357 syrup Nutrition 0.000 claims 1
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- 229940045110 chitosan Drugs 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical group O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 108010076876 Keratins Proteins 0.000 description 7
- 102000011782 Keratins Human genes 0.000 description 7
- 229920001577 copolymer Polymers 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 230000003647 oxidation Effects 0.000 description 6
- 238000007254 oxidation reaction Methods 0.000 description 6
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 6
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 6
- 239000002537 cosmetic Substances 0.000 description 5
- 150000002739 metals Chemical class 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 150000003568 thioethers Chemical group 0.000 description 5
- 229910001312 Amalgam (dentistry) Inorganic materials 0.000 description 4
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 239000002775 capsule Substances 0.000 description 4
- 235000018417 cysteine Nutrition 0.000 description 4
- 239000000448 dental amalgam Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000010408 film Substances 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N hydrogen peroxide Substances OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
- 229920002845 Poly(methacrylic acid) Polymers 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 150000001412 amines Chemical class 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 230000009920 chelation Effects 0.000 description 3
- 239000002131 composite material Substances 0.000 description 3
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 3
- 235000019441 ethanol Nutrition 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 229910001385 heavy metal Inorganic materials 0.000 description 3
- 230000035987 intoxication Effects 0.000 description 3
- 231100000566 intoxication Toxicity 0.000 description 3
- 229940008718 metallic mercury Drugs 0.000 description 3
- 229920000768 polyamine Polymers 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 241000894007 species Species 0.000 description 3
- ACTRVOBWPAIOHC-XIXRPRMCSA-N succimer Chemical compound OC(=O)[C@@H](S)[C@@H](S)C(O)=O ACTRVOBWPAIOHC-XIXRPRMCSA-N 0.000 description 3
- RMVRSNDYEFQCLF-UHFFFAOYSA-N thiophenol Chemical compound SC1=CC=CC=C1 RMVRSNDYEFQCLF-UHFFFAOYSA-N 0.000 description 3
- HNSDLXPSAYFUHK-UHFFFAOYSA-N 1,4-bis(2-ethylhexyl) sulfosuccinate Chemical compound CCCCC(CC)COC(=O)CC(S(O)(=O)=O)C(=O)OCC(CC)CCCC HNSDLXPSAYFUHK-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 206010003805 Autism Diseases 0.000 description 2
- 208000020706 Autistic disease Diseases 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 2
- 239000005977 Ethylene Substances 0.000 description 2
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 2
- JJWSNOOGIUMOEE-UHFFFAOYSA-N Monomethylmercury Chemical compound [Hg]C JJWSNOOGIUMOEE-UHFFFAOYSA-N 0.000 description 2
- 229920000148 Polycarbophil calcium Polymers 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- 239000004376 Sucralose Substances 0.000 description 2
- 239000012670 alkaline solution Substances 0.000 description 2
- 235000012665 annatto Nutrition 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000001045 blue dye Substances 0.000 description 2
- 239000004161 brilliant blue FCF Substances 0.000 description 2
- GEHJBWKLJVFKPS-UHFFFAOYSA-N bromochloroacetic acid Chemical compound OC(=O)C(Cl)Br GEHJBWKLJVFKPS-UHFFFAOYSA-N 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000008119 colloidal silica Substances 0.000 description 2
- BUGICWZUDIWQRQ-UHFFFAOYSA-N copper iron sulfane Chemical compound S.[Fe].[Cu] BUGICWZUDIWQRQ-UHFFFAOYSA-N 0.000 description 2
- 239000008406 cosmetic ingredient Substances 0.000 description 2
- 229960003067 cystine Drugs 0.000 description 2
- 239000000001 dental powder Substances 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 125000002228 disulfide group Chemical group 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 238000004710 electron pair approximation Methods 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 239000000416 hydrocolloid Substances 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 210000004400 mucous membrane Anatomy 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 230000003472 neutralizing effect Effects 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- 229950005134 polycarbophil Drugs 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 239000008279 sol Substances 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 208000003265 stomatitis Diseases 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 235000019408 sucralose Nutrition 0.000 description 2
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 2
- WGPCGCOKHWGKJJ-UHFFFAOYSA-N sulfanylidenezinc Chemical compound [Zn]=S WGPCGCOKHWGKJJ-UHFFFAOYSA-N 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- CWERGRDVMFNCDR-UHFFFAOYSA-N thioglycolic acid Chemical compound OC(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-N 0.000 description 2
- IEXRKQFZXJSHOB-UHFFFAOYSA-N (4-nitrophenyl) formate Chemical compound [O-][N+](=O)C1=CC=C(OC=O)C=C1 IEXRKQFZXJSHOB-UHFFFAOYSA-N 0.000 description 1
- IUTKPPDDLYYMBE-UHFFFAOYSA-N 3,4,5-trihydroxybenzoic acid;hydrate Chemical compound O.OC(=O)C1=CC(O)=C(O)C(O)=C1 IUTKPPDDLYYMBE-UHFFFAOYSA-N 0.000 description 1
- 206010000598 Acrodynia Diseases 0.000 description 1
- 231100000455 Acrodynia Toxicity 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 244000017106 Bixa orellana Species 0.000 description 1
- 206010068065 Burning mouth syndrome Diseases 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 208000032170 Congenital Abnormalities Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012442 Dermatitis contact Diseases 0.000 description 1
- 229940090898 Desensitizer Drugs 0.000 description 1
- 208000019872 Drug Eruptions Diseases 0.000 description 1
- 208000027534 Emotional disease Diseases 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000026139 Memory disease Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- 244000131360 Morinda citrifolia Species 0.000 description 1
- 208000010428 Muscle Weakness Diseases 0.000 description 1
- 206010028372 Muscular weakness Diseases 0.000 description 1
- 206010029155 Nephropathy toxic Diseases 0.000 description 1
- 208000004179 Oral Leukoplakia Diseases 0.000 description 1
- 206010031264 Osteonecrosis Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- IKGXIBQEEMLURG-UHFFFAOYSA-N Rutin Chemical compound OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-UHFFFAOYSA-N 0.000 description 1
- 206010039424 Salivary hypersecretion Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 239000003082 abrasive agent Substances 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 239000001670 anatto Substances 0.000 description 1
- 229910052849 andalusite Inorganic materials 0.000 description 1
- 239000010362 annatto Substances 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000005587 bubbling Effects 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 239000004075 cariostatic agent Substances 0.000 description 1
- 150000001767 cationic compounds Chemical class 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 208000007287 cheilitis Diseases 0.000 description 1
- 239000007910 chewable tablet Substances 0.000 description 1
- 206010009887 colitis Diseases 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 208000010247 contact dermatitis Diseases 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 229910052607 cyclosilicate Inorganic materials 0.000 description 1
- 150000001945 cysteines Chemical class 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 239000007950 delayed release tablet Substances 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 150000002019 disulfides Chemical class 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 229940113960 edetate calcium Drugs 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- PJDVOLYULHZZAG-UHFFFAOYSA-N ethylmercury Chemical compound CC[Hg] PJDVOLYULHZZAG-UHFFFAOYSA-N 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 239000007948 fast release tablet Substances 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 229940097942 gallic acid monohydrate Drugs 0.000 description 1
- ZXQYGBMAQZUVMI-GCMPRSNUSA-N gamma-cyhalothrin Chemical compound CC1(C)[C@@H](\C=C(/Cl)C(F)(F)F)[C@H]1C(=O)O[C@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 ZXQYGBMAQZUVMI-GCMPRSNUSA-N 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 238000001879 gelation Methods 0.000 description 1
- 230000006589 gland dysfunction Effects 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 229940087559 grape seed Drugs 0.000 description 1
- 231100000640 hair analysis Toxicity 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 239000002440 industrial waste Substances 0.000 description 1
- 229910001411 inorganic cation Inorganic materials 0.000 description 1
- 229910052610 inosilicate Inorganic materials 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 229960003511 macrogol Drugs 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 150000002688 maleic acid derivatives Chemical class 0.000 description 1
- 230000006984 memory degeneration Effects 0.000 description 1
- 208000023060 memory loss Diseases 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- XJRBAMWJDBPFIM-UHFFFAOYSA-N methyl vinyl ether Chemical compound COC=C XJRBAMWJDBPFIM-UHFFFAOYSA-N 0.000 description 1
- 239000010811 mineral waste Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 239000010413 mother solution Substances 0.000 description 1
- 210000002200 mouth mucosa Anatomy 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 230000007694 nephrotoxicity Effects 0.000 description 1
- 231100000417 nephrotoxicity Toxicity 0.000 description 1
- 230000002887 neurotoxic effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000017524 noni Nutrition 0.000 description 1
- CCCMONHAUSKTEQ-UHFFFAOYSA-N octadecene Natural products CCCCCCCCCCCCCCCCC=C CCCMONHAUSKTEQ-UHFFFAOYSA-N 0.000 description 1
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 1
- 201000008557 oral mucosa leukoplakia Diseases 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 229910052615 phyllosilicate Inorganic materials 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920006316 polyvinylpyrrolidine Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229940069328 povidone Drugs 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 150000004053 quinones Chemical class 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- WDSFCZDGCAXRDY-UHFFFAOYSA-N s-ethylthiohydroxylamine Chemical compound CCSN WDSFCZDGCAXRDY-UHFFFAOYSA-N 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 208000026451 salivation Diseases 0.000 description 1
- 201000000306 sarcoidosis Diseases 0.000 description 1
- 230000037390 scarring Effects 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229910052851 sillimanite Inorganic materials 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- PDEFQWNXOUGDJR-UHFFFAOYSA-M sodium;2,2-dichloropropanoate Chemical compound [Na+].CC(Cl)(Cl)C([O-])=O PDEFQWNXOUGDJR-UHFFFAOYSA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 229910052606 sorosilicate Inorganic materials 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 229960005346 succimer Drugs 0.000 description 1
- DHCDFWKWKRSZHF-UHFFFAOYSA-N sulfurothioic S-acid Chemical compound OS(O)(=O)=S DHCDFWKWKRSZHF-UHFFFAOYSA-N 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- CNHYKKNIIGEXAY-UHFFFAOYSA-N thiolan-2-imine Chemical compound N=C1CCCS1 CNHYKKNIIGEXAY-UHFFFAOYSA-N 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 239000002351 wastewater Substances 0.000 description 1
- 239000003021 water soluble solvent Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
- A61K8/447—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof containing sulfur
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/042—Gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/736—Chitin; Chitosan; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8158—Homopolymers or copolymers of amides or imides, e.g. (meth) acrylamide; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/51—Chelating agents
Description
D E S C R I Z I O N E DESCRIPTION
POLIMERI E COMPOSIZIONI PER LA PREVENZIONE O IL TRATTAMENTO DI DETOSSICAZIONE MUCOSALE DA MERCURIO ELEMENTARE E BIVALENTE POLYMERS AND COMPOSITIONS FOR THE PREVENTION OR TREATMENT OF MUCOSAL DETOXIFICATION BY ELEMENTARY AND BIVALENT MERCURY
CAMPO DELL’INVENZIONE FIELD OF INVENTION
L’invenzione si riferisce all’uso di polìmeri non-assorbibili in composizioni utili per la prevenzione o la detossicazione simultanea del mercurio elementare e bivalente dalle mucose orofaringee-gastrointestìnalì . The invention refers to the use of non-absorbable polymers in compositions useful for the prevention or simultaneous detoxification of elemental and divalent mercury from the oropharyngeal-gastrointestinal mucosa.
STATO DELL’ARTE STATE OF THE ART
La problematica dell’amalgama dentale à ̈ stata discussa approfonditamente nel precedente brevetto IT2009MI02147. Oltre all’amalgama dentale, le principali fonti di mercurio sono i pesci predatori dì grosse dimensioni, l’acqua potabile contaminata da reflui industriali e l'agricoltura in presenza di antifungicidi mercuriali. Le peggiori conseguenze dell’accumulo di Hg sono gli effetti neurotossici sui bambini (Environ Health Perspect. 2000; I08;A250-1 e A262) e la correlazione con l’insorgenza di autismo (Med Hypoth. 2001 ; 56(4):462-71). The problem of dental amalgam has been discussed in depth in the previous patent IT2009MI02147. In addition to dental amalgam, the main sources of mercury are large predatory fish, drinking water contaminated by industrial waste and agriculture in the presence of mercurial antifungicides. The worst consequences of the accumulation of Hg are the neurotoxic effects on children (Environ Health Perspect. 2000; I08; A250-1 and A262) and the correlation with the onset of autism (Med Hypoth. 2001; 56 (4) : 462-71).
Con un livello di intossicazione sub-critico, senza chiare evidenze patologiche, à ̈ comunque opportuno effettuare un’analisi diagnostica. La conferma di uno stato di intossicazione à ̈ peraltro realizzabile con l’analisi del capello in quanto i livelli assoluti di mercurio nei capelli sono circa 300 volte superiori a quelli del sangue, e risultano quindi più attendibili. With a sub-critical level of intoxication, without clear pathological evidence, it is still advisable to carry out a diagnostic analysis. The confirmation of a state of intoxication is also achievable with the analysis of the hair as the absolute levels of mercury in the hair are about 300 times higher than those of the blood, and are therefore more reliable.
Alcuni sistemi di disintossicazione “soft†di mercurio e di metalli pesanti sono basati sull’alimentazione integrata con elementi chelanti quali selenio, zinco e vitamina C. Some 'soft' mercury and heavy metal detoxification systems are based on a diet supplemented with chelating elements such as selenium, zinc and vitamin C.
La chelazione farmacologica con acido meso-2,3 -dimercaptosuccinico (DMSA; succìmer) e con acido 2,3 dimercapto l-propansolfonico (DMPS) sono utilizzate nelle forme clinicamente rilevanti di intossicazioni da mercurio. In Clin Toxicol (Phila). 2009; 47{9):84l-58 si evidenzia come il DMSA ed il calcio edetato disodico forniscano buoni risultati ma con effetti collaterali per chelazione aspecifica di Zn e Cu, con episodi di nefrotossicità e mucotossicìtà In generale si riconosce inoltre ai chelanti solforati a basso peso molecolare un rischio della ridistribuzione sistemica del mercurio. Per questo sono preferiti sono materiali non-assorbibili in grado di captare il mercurio senza ridistribuirlo nell’organismo. Pharmacological chelation with meso-2,3-dimercaptosuccinic acid (DMSA; succìmer) and with 2,3 dimercapto l-propane sulfonic acid (DMPS) are used in clinically relevant forms of mercury poisoning. In Clin Toxicol (Phila). 2009; 47 {9): 84l-58 it is highlighted how DMSA and disodium edetate calcium provide good results but with side effects due to non-specific chelation of Zn and Cu, with episodes of nephrotoxicity and mucotoxicity. low molecular weight a risk of the systemic redistribution of mercury. For this reason, non-absorbable materials that are able to capture mercury without redistributing it in the body are preferred.
I brevetti US5178541 e WO9010433 descrivono l’uso dello zolfo elementare per la rimozione dei mercurio odontologico. Con analogo proposito US 2004180788 descrive un carbone attivo con depositate particelle d’oro mediante processo non elettrolitico; mentre EP 1348417 utilizza cellulosa adsorbita con tiosolfatì e seleniti alcalini, EDTA e/o DMPS. Altri materiali come le resine troiate sono state sperimentate in passato per la detossicazione orale del mercurio, ad es. da Clarkson TW e coll, (J Pharmacol Exp Ther. 1981; 218(i):74-83), Aaseth & Frieheim (Acta Pharmacol Toxicol. 1978; 42(4):248-52), e da Cikrt & Lenger (Toxicol Lett, 1980; 5:51-4) sia da sole che in combinazione con classici chetanti dolici a basso peso molecolare, ottenendo discreti ma non eccellenti risultati. Patents US5178541 and WO9010433 describe the use of elemental sulfur for the removal of odontological mercury. With the same purpose US 2004180788 describes an activated carbon with gold particles deposited by a non-electrolytic process; while EP 1348417 uses cellulose adsorbed with thiosulfate and alkaline selenites, EDTA and / or DMPS. Other materials such as trojan resins have been tried in the past for the oral detoxification of mercury, eg. by Clarkson TW et al, (J Pharmacol Exp Ther. 1981; 218 (i): 74-83), Aaseth & Frieheim (Acta Pharmacol Toxicol. 1978; 42 (4): 248-52), and by Cikrt & Lenger ( Toxicol Lett, 1980; 5: 51-4) both alone and in combination with classic low molecular weight dolic ketants, obtaining fair but not excellent results.
Si conferma pertanto l’utilità di disporre di un’efficace composizione in grado di risolvere l’intossicazione da mercurio elementare e bivalente nelle mucose del tratto orofaringeo e gastrointestinale in soggetti con sintomi evidenti o latenti da sovra-esposizione a mercurio. SOMMARIO The usefulness of having an effective composition capable of resolving elemental and bivalent mercury intoxication in the mucous membranes of the oropharyngeal and gastrointestinal tract is therefore confirmed in subjects with evident or latent symptoms of over-exposure to mercury. SUMMARY
Si à ̈ verificato che un efficiente captazione dell’ insieme del mercurio elementare e bivalente rilasciato da otturazioni in amalgama può essere realizzato in presenza di polimeri puri o in combinazioni tali da fornire la concomitante presenza di gruppi funzionali in grado di chelare il mercurio bivalente ed altri in grado di captare il mercurio elementare. It has been verified that an efficient uptake of the whole elemental and divalent mercury released from amalgam fillings can be achieved in the presence of pure polymers or in combinations such as to provide the concomitant presence of functional groups capable of chelating divalent mercury and others capable of capturing elemental mercury.
In un aspetto l invenzione si riferisce all' uso di polimeri aventi doppia funzionalità in composizioni utili per la prevenzione o la detossicazione simultanea del mercurio elementare e bivalente da otturazioni in amalgama o da fonti alimentari. In one aspect the invention relates to the use of polymers having dual functionality in compositions useful for the simultaneous prevention or detoxification of elemental and divalent mercury from amalgam fillings or from food sources.
In un altro aspetto l invenzione sì riferisce all' uso di opportune associazioni di polimeri in composizioni utili per la prevenzione o detossicazione commbinata del mercurio elementare e bivalente da otturazioni in amalgama o da fonti alimentari, In another aspect, the invention refers to the use of suitable associations of polymers in compositions useful for the prevention or combined detoxification of elemental and divalent mercury from amalgam fillings or from food sources,
DESCRIZIONE DETTAGLIATA DETAILED DESCRIPTION
Nel contesto inventivo il termine “mercurio bivalente†definirà di seguito definisce le varie forme di mercurio bivalente (lì) pertanto comprendenti sia il catione inorganico (Hg<++>) che le specie parzialmente organicate come metilmercurio (MeHg*) e etilmercurio (EtHg<+>), di seguito complessivamente denominato per brevità “Hg(II)†. In the inventive context the term â € œdivalent mercuryâ € will define below the various forms of divalent mercury (there) therefore including both the inorganic cation (Hg <++>) and the partially organic species such as methylmercury (MeHg *) and ethylmercury (EtHg <+>), hereinafter collectively referred to as â € œHg (II) â €.
Nel presente ambito il termine “mercurio elementare" definisce il mercurio metallico o “Hg(0)†in forma molecolare liquida o di particelle di vapore finemente disperse o atomizzate. I materiali utilizzati nella presente invenzione sono in grado dì captare sia Hg(0) che Hg(IT), in alcuni casi possedendo entrambe le funzionalità , in altri mediante opportuna combinazione. Si à ̈ sorprendentemente trovato che i tiopolimeri con gruppi disolfuro e tiolici sono in grado di captare rispettivamente Hg(G) e Hg(II). Difetti se la chelazione tiolo-Hg(II) era prevedibile, lo stesso non si poteva dire della captazione dì (Hg(0) da parte del gruppo di solfuro considerando i potenziali E<o>(V)Hg<MVHg(0) = 0,85 e E°(V)SS/2SH<=>+0,25 non favorevoli. In the present context, the term â € œelemental mercury "defines metallic mercury or â € œHg (0) â € in liquid molecular form or finely dispersed or atomized vapor particles. The materials used in the present invention are capable of capturing both Hg (0) and Hg (IT), in some cases possessing both functions, in others by means of a suitable combination. It has been surprisingly found that thiopolymers with disulfide and thiol groups are able to uptake Hg (G) and Hg ( II). Defects If the thiol-Hg (II) chelation was predictable, the same could not be said of the uptake of (Hg (0) by the sulphide group considering the potentials E <o> (V) Hg <MVHg (0) = 0.85 and E ° (V) SS / 2SH <=> + 0.25 not favorable.
Polimeri utili in grado dì captare simultaneamente Hg(0) e Hg(II) comprendono: Useful polymers capable of simultaneously capturing Hg (0) and Hg (II) include:
a) polimeri dolati in forma di resine tioliche parzialmente ossidate, cioà ̈ contenenti contemporaneamente gruppi tiolici (-SH) e gruppi disolfuro (-SS-), dove ì primi hanno catturano il Hg(II) mentre i secondi captano il Hg(0) con meccanismo redox; a) polymers in the form of partially oxidized thiol resins, i.e. containing thiol groups (-SH) and disulfide groups (-SS-) at the same time, where the former capture Hg (II) while the latter capture Hg (0 ) with redox mechanism;
b) polimeri dolati in forma di tiomeri parzialmente ossidati, contenenti gruppi tiolici (-SH) e disolfuro (-SS-), attivi con meccanismo analogo ai polimeri (a). b) polymers in the form of partially oxidized thiomers, containing thiol groups (-SH) and disulfide (-SS-), active with a mechanism similar to polymers (a).
c) polimeri tioi-cheratinici naturali, idrolizzati e/o derivatizzati contenenti sia la cisteina (-Cys-SH) che la cistina (-Cys-SS-Cys-), attivi analogamente ai polimeri (a) e (b); d) polimeri metanici di tipo naturale o sintetico, contenenti contemporaneamente gruppi ionici o ionizzabili tipo carbossilici (COOH), fenolici (Ar-OH), catecholici (Ar-(OH)2e/o amminici (R-NH) e inoltre gruppi ad attività redox come chinoni e semìchinoni, dove i primi hanno funzione sequestrante su Hg(Il) mentre i secondi dimostrano capacità di captazione con meccanismo redox radicalico del Hg(0). c) natural, hydrolyzed and / or derivatized thioi-keratin polymers containing both cysteine (-Cys-SH) and cystine (-Cys-SS-Cys-), active analogously to polymers (a) and (b); d) natural or synthetic methane polymers, simultaneously containing ionic or ionizable carboxylic (COOH), phenolic (Ar-OH), catecholic (Ar- (OH) 2 and / or amino (R-NH) groups and also activity groups redox such as quinones and semquinones, where the former have a sequestering function on Hg (II) while the latter demonstrate the ability to capture Hg (0) with a redox radical mechanism.
1 polimeri del tipo da (d) a (d) possono essere combinati con polimeri utili alla captazione dei mercurio elementare a fornire un ampio spettro di prevenzione o detossicazione da mercurio. Polimeri utili in grado di captare specificamente il Hg(II) comprendono: The polymers of the type from (d) to (d) can be combined with polymers useful for the uptake of elemental mercury to provide a wide spectrum of prevention or detoxification from mercury. Useful polymers capable of specifically capturing Hg (II) include:
e) polimeri amminici, o poliammìne naturali o sintetiche, ad esempio chi tosano naturale, modificato o reticolato, o poliammìne sintetiche ad alto peso molecolare di sintesi. 0 polimeri con coppia di gruppi carbossilici geminali o vicinali, cioà ̈ (polì)immìdoacetico (HOOOC-CHP-COOH) e (poli)maleico (HOOOC-CH-CHP-COOH). e) amine polymers, or natural or synthetic polyamines, for example natural, modified or cross-linked sheaves, or synthetic high molecular weight synthetic polyamines. 0 polymers with a pair of geminal or vicinal carboxylic groups, ie (polì) immìdoacetic (HOOOC-CHP-COOH) and (poly) maleic (HOOOC-CH-CHP-COOH).
g) polimeri inorganici fio-attivati quali allumina e silice e allumosilicati sui cui sono adsorbite molecole solforate utili per la captazione del Hg(ll) come il dimetti so fossido (DMSO), oppure funzionalizzati con gruppi solfuro-disolfuro. g) flo-activated inorganic polymers such as alumina and silica and alumosilicates on which sulfur molecules useful for the uptake of Hg (ll) such as dimetide (DMSO), or functionalized with sulphide-disulfide groups, are adsorbed.
I polimeri del tipo da (e) a (g) a captazione di Hg(ll) sono utilmente combinati con polimeri a captazione di Hg(0) a fornire un ampio spettro di prevenzione o detossicazione da mercurio. Polimeri in grado di captare specificamente il Hg(0) comprendono: Hg (ll) uptake type (e) to (g) polymers are usefully combined with Hg (0) uptake polymers to provide a broad spectrum of mercury prevention or detoxification. Polymers capable of specifically capturing Hg (0) include:
h) polimeri adsorbiti con metalli in forma elementare finemente dispersi quali oro, argento, zinco, alluminio, rame ed altri metalli non tossici formanti Hg-amalgama, ì) polimeri adsorbiti con solfuri naturali o sintetici finemente dispersi quali argentite (AgS), sfalerite (ZnS), pirite (FeS) e calcopirite (CuFeS2) in grado di reagire, incorporando, il mercurio Hg(0). h) polymers adsorbed with finely dispersed metals in elemental form such as gold, silver, zinc, aluminum, copper and other non-toxic metals forming Hg-amalgam, ì) polymers adsorbed with finely dispersed natural or synthetic sulphides such as silverite (AgS), sphalerite (ZnS), pyrite (FeS) and chalcopyrite (CuFeS2) capable of reacting by incorporating mercury Hg (0).
I polimeri del tipo da (a) a (f) possono inoltre essere usati anche in combinazione con addotti polimero-ossidante utili a favorire la conversione di Hg(0) in Hg(II). The polymers of the type (a) to (f) can also be used in combination with polymer-oxidant adducts useful for promoting the conversion of Hg (0) into Hg (II).
Polimeri in grado di favorire tale conversione a bivalente comprendono ad esempio: Polymers capable of promoting this conversion to bivalent include, for example:
j) compositi di polimero con agente ossidante, tipo l’associazione povidone-perossido di idrogeno (PVP-H2O2), dove quest’ultimo favorisce la conversione di Hg(0) in Hg<44>. Le caratteristiche dei polimeri sopra illustrati, da (a) a (j), utilizzabili per la produzione delle composizioni secondo l’invenzione sono meglio specificati di seguito in forma esemplificativa, sebbene non limitativa. j) polymer composites with oxidizing agent, such as the association povidone-hydrogen peroxide (PVP-H2O2), where the latter favors the conversion of Hg (0) into Hg <44>. The characteristics of the polymers illustrated above, from (a) to (j), which can be used for the production of the compositions according to the invention, are better specified below in exemplary, although not limiting, form.
1 polimeri tiolati in forma di resine parzialmente ossidata (a) sono ottenuti per parziale ossidazione delle resine tiolate generalmente prodotte per la separazione di metalli pesanti da reflui e acque di trattamento, ad es. di scorie minerarie, previamente micronizzate. The thiolated polymers in the form of partially oxidized resins (a) are obtained by partial oxidation of the thiolated resins generally produced for the separation of heavy metals from wastewater and treatment water, e.g. of mineral waste, previously micronized.
Parte dei gruppi tiolici sono convertiti in disolfuri mediante ossidanti blandi, ad es. per esposizione ail’O2atmosferico o in soluzioni iodate in presenza di 02, preferìbilmente in ambiente basico. Part of the thiol groups are converted to disulfides by mild oxidants, e.g. by exposure to atmospheric O2 or in iodized solutions in the presence of 02, preferably in a basic environment.
Un esempio preferito à ̈ Ambersepâ„¢ GT74 (ex Duolite GT73) fornita da Rohm and Haas -Dow Corp., resina polistirolica tiofenolica con conc. di gruppi dolici pari a 1 ,3 eq/1. Altri esempi di resine tiolate sono XUS-43604 da Dow Corp.; Lewatitâ„¢ Monoplus TP214 da Lanxess AG (Germ.); Puroliteâ„¢ S924 da Puro lite Int (Baia Cynwyd, PA, USA). A favorite example is Ambersepâ „¢ GT74 (formerly Duolite GT73) supplied by Rohm and Haas-Dow Corp., thiophenol polystyrol resin with conc. of dolic groups equal to 1, 3 eq / 1. Other examples of thiolated resins are XUS-43604 from Dow Corp .; Lewatitâ „¢ Monoplus TP214 from Lanxess AG (Germ.); Puroliteâ „¢ S924 from Puro lite Int (Cynwyd Bay, PA, USA).
Dette resine sono commercializzate in forma dì macrobeads porosi (da 1000 a 300 micron) pertanto le resine devono essere macinate a < 100 pm, preferibilmente < 60 pm e quindi sottoposte a trattamento di parziale ossidazione a secco o ad umido, es. in corrente d’aria calda, per convertire i gruppi tiolici in gruppi disolfuro. Said resins are marketed in the form of porous macrobeads (from 1000 to 300 microns) therefore the resins must be ground at <100 µm, preferably <60 µm and then subjected to dry or wet partial oxidation treatment, eg. in a stream of hot air, to convert the thiol groups into disulfide groups.
Altri polimeri tiolati sono in forma di idrocolloidi parzialmente ossidati (a) ottenuti per parziale ossidazione da idrocolloide tio-funzìonalizzati, detti “idrocolloide tiolato†0 “tiomero†ad es. descritti da Vauthier & Bouchemal (Pharm Res. 2009; 26:5:1025-58). Other thiolated polymers are in the form of partially oxidized hydrocolloids (a) obtained by partial oxidation from thio-functionalized hydrocolloid, called â € œthiolated hydrocolloidâ € or â € œtiomerâ € eg. described by Vauthier & Bouchemal (Pharm Res. 2009; 26: 5: 1025-58).
I tiomeri utili nei contesto inventivo sono dettagliati in WO/2007/071375 (Unilever) e comprendono: i) tiomeri carbossilici {in genere) tiolati con cisteina; ii); tiomeri ottenuti per delazione di polietilenimine, descritte a seguire, e iiii) tiomeri con gruppi ossidrilìci tiolati con 2-iminotiolano (reagente di Traut’s) attivati per reazione con estere cloroformiato attivato (es. 4-nitrofenilformiato) e infine reagiti con un dolo bi -funzionale come il 2-aminotioetanoIo, Esempi di tiomeri comprendono polycarbophil tiolati, acidi poli( met)acrilici (PAA) tiolati, cellulosa tiolata, alginati o pectine troiate, chi tosano tiolato, jualuronan fidato, polii isina e poliarginìna tiolate, PEG stearato tiolato. Sono disponibili polycarbophil tiolato, PAA tiolato e chitosano tiolato prodotti da ThioMatriX GmbH (Innsbruk, Austria) o producibili mediante metodi noti, ad es. Cevher (AAPS PharmSciTeeh, 2008; 9(3):953-65) o come da esempio 1B. Ulteriori esempi di tiomeri utili comprendono i chitosano-iminotiolattoni descritti in WO/2003/020771 da MucoBiomer GmbH (Leobendorf, Austria); lo Spheron Thiol 1000, gelresina metacrilica tiolata da Lachema (Bmo, Repubblica Ceca); i polialchilglicoli tiolati descritti in WO/2008/123389 da Nippon Shokubai (Osaka, J), ed altri ancora quali ad esempio la serie dei tiomeri prodotta ed offerta da CarboMer Ine. (San Diego, CA, USA). The thiomers useful in the inventive context are detailed in WO / 2007/071375 (Unilever) and include: i) carboxylic thiomers (generally) thiolated with cysteine; ii); thiomers obtained by delation of polyethylenimines, described below, and iiii) thiomers with hydroxy groups thiolated with 2-iminothiolan (Trautâ € ™ s reagent) activated by reaction with activated chloroformate ester (eg 4-nitrophenylformate) and finally reacted with a bi-functional dolo such as 2-aminothioethane, Examples of thiomers include polycarbophil thiolates, poly (meth) acrylic acids (PAA) thiolates, thiolated cellulose, alginates or troiate pectins, chi tosan thiolate, trusted jualuronan, polyisine and polyargin na thiolate, PEG thiolate stearate. Polycarbophil thiolate, PAA thiolate and chitosan thiolate are available manufactured by ThioMatriX GmbH (Innsbruk, Austria) or can be manufactured by known methods, e.g. Cevher (AAPS PharmSciTeeh, 2008; 9 (3): 953-65) or as in example 1B. Further examples of useful thiomers include the chitosan-iminothiolactones described in WO / 2003/020771 by MucoBiomer GmbH (Leobendorf, Austria); Spheron Thiol 1000, thiolated methacrylate gelresin from Lachema (Bmo, Czech Republic); the thiolated polyalkylglycols described in WO / 2008/123389 by Nippon Shokubai (Osaka, J), and others such as for example the series of thiomers produced and offered by CarboMer Ine. (San Diego, CA, USA).
Detti tiomeri prima dell’incorporazione nelle composizioni inventive saranno sottoposti a trattamento di parziale ossidazione, di preferenza ad umido, ad es. in soluzione neutra o alcalina con aria per convertire parte dei gruppi dolici in gruppi di solfuro. Said thiomers before incorporation into the inventive compositions will be subjected to partial oxidation treatment, preferably wet, eg. in neutral or alkaline solution with air to convert part of the dolic groups into sulphide groups.
I polimeri tiolati, resine tiolate o tiomeri, conterranno tipicamente una quantità di gruppi attivi -SH o disolfuro -SS- compresi tra 10 e 0,1 meq/g di polimero, preferibilmente tra 1,5 e 0,15 meql/g, con rapporto -SH e -SS- compreso tra 10:1 e 1 : 10, preferibilmente tra 5:1 e 1 :5. I polimeri cherafinici (c) utili per i nostri scopi possono essere di tipo le cheratine di origine umana e animale, parzialmente idrolizzate e/o chimicamente modificate naturalmente contenenti diverse proporzioni dei gruppi cisterna (-Cys-SH) e cistina (~Cys~SS-Cys-), che pertanto agiscono con meccanismo analogo ai polimeri (a). The thiolated polymers, thiolated resins or thiomers, will typically contain a quantity of active groups -SH or disulfide -SS- comprised between 10 and 0.1 meq / g of polymer, preferably between 1.5 and 0.15 meql / g, with ratio -SH and -SS- between 10: 1 and 1: 10, preferably between 5: 1 and 1: 5. The keratin polymers (c) useful for our purposes can be of the type keratins of human and animal origin, partially hydrolyzed and / or chemically modified naturally containing different proportions of the cisterna (-Cys-SH) and cystine (~ Cys ~ SS) groups -Cys-), which therefore act with a mechanism similar to polymers (a).
Esempi utili di tali polimeri sono le cheratine cosmetiche dal 2010 International Cosmetic Ingredient Dictionary and Handbook, 13th Ed„ ad esempio fornite da Cognis (Monheim am Rhein, D), Croda (East Yorkshire, UK) Fabriquimica (San Martin, Arg.) Gattefosse (Saint Priest, F), Kemira Specialty (Northvale, NJ, USA), Seiwa Kasei (Osaka, J) Seppie (Paris La Defense, F) Variati & Co (Conco rezzo, MI, IT) Vincience (Sophia Antipolis, F) Useful examples of such polymers are cosmetic keratins from 2010 International Cosmetic Ingredient Dictionary and Handbook, 13th Edâ € ž for example provided by Cognis (Monheim am Rhein, D), Croda (East Yorkshire, UK) Fabriquimica (San Martin, Arg.) Gattefosse (Saint Priest, F), Kemira Specialty (Northvale, NJ, USA), Seiwa Kasei (Osaka, J) Seppie (Paris La Defense, F) Variati & Co (Conco rezzo, MI, IT) Vincience (Sophia Antipolis, F )
Detti polimeri cheratinìci possono essere incorporati come tali nelle composizioni, o sottoposti a tratamento di parziale ossidazione, ad esempio con aria, nel caso si desideri aumentare il contenuto di gruppi cistica rispetto alla cisteina e/o se à ̈ richiesta un’ulteriore diminuzione della loro solubilità in ambiente fisiologico-acquoso (mucose). Said keratinic polymers can be incorporated as such in the compositions, or subjected to partial oxidation treatment, for example with air, if it is desired to increase the content of cystic groups with respect to cysteine and / or if a further decrease of their solubility in aqueous-physiological environment (mucous membranes).
I polimeri melanici (c) per i nostri scopi possono essere di tipo naturale o sintetico, laddove la contemporanea presenza di gruppi ionici o ionizzabìli e di gruppi ad attività redox come chi noni e semichinoni consente la simultanea captazione di mercurio bivalente e metallico. Si possono ottenere strutture melaniniche mediante la classica ossidazione in aria di tìrosina o di 1-Dopa in presenza di enzima tirosinasi (da funghi) o per polimerizzazione ossidativa in soluzione alcalina di precursori melanici classici come 1-Dopa e catecolo o in combinazione con precursori vegetali (polifenoli) a dare le melanine vegetali, o “fitomelanine†. The melanic polymers (c) for our purposes can be of the natural or synthetic type, where the simultaneous presence of ionic or ionizable groups and groups with redox activity such as chi noni and semiquinones allows the simultaneous uptake of divalent and metallic mercury. Melanin structures can be obtained by the classic oxidation in air of thérosine or 1-Dopa in the presence of tyrosinase enzyme (from fungi) or by oxidative polymerization in an alkaline solution of classical melanic precursors such as 1-Dopa and catechol or in combination with plant precursors (polyphenols) to give plant melanins, or â € œphithomelaninsâ €.
II polimero melanieo può essere isolato per precipitazione a pH acido o diluizione in solventi idrosolubili (etanolo) dalla soluzione madre e raccolto per centrifugazione/fìltrazione. Esempi utili di tali polimeri sono le melanine cosmetiche offerte da diversi fornitori del 2010 International Cosmetic Ingredient Dictionary and Handbook, 13th Ed., es. da Vincience (F), Active Concepts (Piscataway, NJ, USA), Creations Couleurs (Dreux, F), Frances Christian Gaskin, Ine. (Albany, NY, USA), Lipo Chemicals Ine. (Paterson, NJ), Lipotec S.A. (Barcelon, S); oppure ibridi come la Phytomelaninâ„¢ (Dr. Carlo Ghisalberti) e la Vegetable Melanin di Active Concepts e Creations Couleurs; ed inoltre melanine derivatizzate come AC Melanin Quatemium- 10 e SilanetrioI Melaninate da Active Concepts. The melanieo polymer can be isolated by precipitation at acid pH or dilution in water-soluble solvents (ethanol) from the mother solution and collected by centrifugation / filtration. Useful examples of such polymers are the cosmetic melanins offered by various suppliers of the 2010 International Cosmetic Ingredient Dictionary and Handbook, 13th Ed., Ex. da Vincience (F), Active Concepts (Piscataway, NJ, USA), Creations Couleurs (Dreux, F), Frances Christian Gaskin, Ine. (Albany, NY, USA), Lipo Chemicals Ine. (Paterson, NJ), Lipotec S.A. (Barcelon, S); or hybrids such as Phytomelaninâ „¢ (Dr. Carlo Ghisalberti) and Vegetable Melanin by Active Concepts and Creations Couleurs; and also derivatized melanins such as AC Melanin Quatemium-10 and SilanetrioI Melaninate from Active Concepts.
Si à ̈ trovato che i polimeri (a)-(d) possono effettuare la rimozione simultanea del mercurio elementare e bivalente, quindi sono particolarmente utili nell' ambito inventivo. It has been found that the polymers (a) - (d) can effect the simultaneous removal of elemental and divalent mercury, therefore they are particularly useful in the inventive field.
Altri polimeri (e)-(g), descritti in dettaglio, si dimostrano particolarmente efficaci su Hg(II). Other polymers (e) - (g), described in detail, prove particularly effective on Hg (II).
1 polimeri aminici e amino-tiolìci (e) hanno gruppi amminici ed evenutali tiolici nonossidatì. Esempio di polimeri amminici sono il chitosano naturale o reticolato, come i Chitopharmâ„¢ L, M e S da Cognis (Monheim, D). Altri chitosani con grado di de aceti 1 azione tra 60 e 100% ad es. da fornitori citati nel 2010 International Cosmetìc Ingredient Dictionary and Handbook, 13th Ed., alla voce “chitosan†(INC1). Esempi di chitosano reticolato sono ad es. descritti in AAPS PharmSciTech 2006; 7 (2):E2-E6 oppure nel brevetto US5015293. The amino and amino-thiol polymers (e) have non-oxidized amino and even thiol groups. Examples of amine polymers are natural or cross-linked chitosan, such as Chitopharmâ „¢ L, M and S from Cognis (Monheim, D). Other chitosans with degree of de vinegar 1 action between 60 and 100% eg. from suppliers mentioned in 2010 International Cosmetìc Ingredient Dictionary and Handbook, 13th Ed., under the entry â € œchitosanâ € (INC1). Examples of cross-linked chitosan are e.g. described in AAPS PharmSciTech 2006; 7 (2): E2-E6 or in US patent 5015293.
Esempio di polimeri amminici sono le poliammine sintetiche che comprendono polietilenimine ramificate [9002-98-6] Sigma-Ai drich cat. N. 408727 e polietilenimine in soluzione [9002-98-6] Sigma-AIdrieh cat. N. P3143, 03880, 482595, 408700 e 181978. Example of amine polymers are synthetic polyamines which include branched polyethylenimines [9002-98-6] Sigma-Ai drich cat. No. 408727 and polyethylenimines in solution [9002-98-6] Sigma-AIdrieh cat. Nos. P3143, 03880, 482595, 408700 and 181978.
Esempio di polimeri ammino-tiolici sono i polimeri del tipo tio-funzionalizzato con cisteine o acido tioglicolico o del tipo tiolato con reagenti eterobi funzionali come N-suecinimdyI-3-(pyridyldìthio) propinate o con 2-iminotìolano (reagente di Traut’s). Example of amino-thiol polymers are polymers of the thio-functionalized type with cysteines or thioglycolic acid or of the thiolated type with functional heterobes such as N-suecinimdyI-3- (pyridyldìthio) propinate or with 2-iminotìolano (reagent of Trautâ € ™ s).
I polìmeri con coppie di carbossili geminali o vicinali (f) comprendono (poli)immidoacetati (HOOOC-CHP-COOH)n e (poli)maleati (HOOOC-CH-CHP-COOH)n, dove P indica la componente polimerica al quale sono collegati detti gruppi funzionali. Polymers with geminal or vicinal carboxyl pairs (f) include (poly) imidoacetates (HOOOC-CHP-COOH) n and (poly) maleates (HOOOC-CH-CHP-COOH) n, where P indicates the polymeric component to which said functional groups are connected.
1 poliiminodiacetati sono generalmente ottenuti per post-modificazione di polieri e resine preformate, con linker tipo gruppo glicidile come descritto da Qaykara T et al. Mater Scien Engin. C, 2009; 29:20-4. Polyiminoacetates are generally obtained by post-modification of preformed polyers and resins, with glycidyl group linkers as described by Qaykara T et al. Mater Scien Engin. C, 2009; 29: 20-4.
Esempi di poliiminodiacetati comprendono: Amberliteâ„¢ IRC748I da Rohm & Haas-Dow, Diaionâ„¢ CRI 1 da Mitsubishi, Lewatìtâ„¢ TP 207 da Lanxess GmbH; Chelex 100 da Sigma-Aìdrich cat. N- C790I; IDA-agarose da Sigma- Aldrich cat. N, 14758; IDA-coupled Sepharoseâ„¢ Fast Flow da GE Healthcare; e Dionex ProPac IMAC-10â„¢ da Dionex Corp. Examples of polyiminodiacetates include: Amberliteâ „¢ IRC748I from Rohm & Haas-Dow, Diaionâ„ ¢ CRI 1 from Mitsubishi, Lewatìtâ „¢ TP 207 from Lanxess GmbH; Chelex 100 from Sigma-Aìdrich cat. N-C790I; IDA-agarose from Sigma- Aldrich cat. N, 14758; IDA-coupled Sepharoseâ „¢ Fast Flow from GE Healthcare; and Dionex ProPac IMAC-10â „¢ from Dionex Corp.
I polimaleati sono otenibili per comopolimerizzazione radicaiica dell’anidride maleica per con altri monomeri etilenici. Esempi di polimaleati comprendono copolimeri methyl vinyl ether/MA Gantrezâ„¢ AN-139 e AN-I69 da ISP (Winston-Salem, NC, USA), copolimero Ethylene/MA/Propylene ZeMacâ„¢ da Vertellus (Indianapolis, IN, USA), copolimero Octadecene/MA da Chevron (Boston, MA, USA), copolimero PVM/MA Luvifonnâ„¢ FA 139 da BASF (Ludwigshafen, D) e copolimero C4-12 Olefin/MA da Kao Corp. (Wakayama-shi, J), dove MA = acido o anidride maleica. The polymaleates can be obtained by comopolymerization of the maleic anhydride with other ethylene monomers. Examples of polymaleates include methyl vinyl ether / MA Gantrezâ „¢ AN-139 and AN-I69 copolymers from ISP (Winston-Salem, NC, USA), Ethylene / MA / Propylene ZeMacâ„ ¢ copolymer from Vertellus (Indianapolis, IN, USA) , Octadecene / MA copolymer from Chevron (Boston, MA, USA), PVM / MA Luvifonnâ „¢ FA 139 copolymer from BASF (Ludwigshafen, D) and C4-12 Olefin / MA copolymer from Kao Corp. (Wakayama-shi, J) , where MA = maleic acid or anhydride.
I polimeri inorganici tio-attivati (g) comprendono allumina e silice e allumosilicati sui quali sono adsorbite molecole solforate utili per la captazione del Hg(il) come il dimetilsofossido (DMSO), oppure funzionai izzati con gruppi solfuro-disolfuro-In particolare si possono ottenere dete attivazione per semplice mescolamento a secco o in solvente di allumina, silice gel, neosilicati, sorosilicati, ciclosilicati, inosilicati, fillosilicati e tectosiiicatiinati, caolino, argille (es. bentonite), andalusite, sillimanite e zeoliti possono essere tio-attivate per adsorbimento con opportuno solforato quale il dimetilsol fossido, ad es, come illustrato da Soliman e coll. (Talanta 2006; 69(l):55-60). The thio-activated inorganic polymers (g) include alumina and silica and alumosilicates on which sulfur molecules useful for the uptake of Hg (II) such as dimethylsophoxide (DMSO) are adsorbed, or functionalized with sulphide-disulfide groups. obtain activation by simple dry or solvent mixing of alumina, silica gel, neosilicates, sorosilicates, cyclosilicates, inosilicates, phyllosilicates and tectosiiicates, kaolin, clays (e.g. bentonite), andalusite, sillimanite and zeolites can be thio-activated by adsorption with a suitable sulphide such as fossid dimethylsol, for example, as illustrated by Soliman et al. (Talanta 2006; 69 (l): 55-60).
Sì à ̈ trovato che i polimeri (e)-(g) possono effettuare la rimozione seletiva del Hg(ll), mentre risultano poco attivi sul mercurio elementare. Yes, it has been found that polymers (e) - (g) can perform the selective removal of Hg (ll), while they are not very active on elemental mercury.
In un ambito inventivo sono associati a materiali in grado di agire da captatori di mercurio elementare quali i metalli formanti amalgama ed i solfuri. In an inventive field they are associated with materials capable of acting as elemental mercury collectors such as amalgam forming metals and sulphides.
Polimeri con adsorbiti metalli in forma elementare finemente dispersi (h) quali oro, argento, zinco, alluminio, rame ed altri metalli non tossici in grado di formare amalgama con IIg(0), sono ad es. ottenute come da J Biomater Sci Polym Ed 2009, 20(3):311-24 o Carb Polymers 2006, 65:430-34 o vendute come sosp. 3% su biopoiimero, denominate “Nano Biosi 1 ver†. Polimeri con adsorbiti solfuri finemente dispemi (i) quali argenti te (AgS), sfalerite (ZnS), pirite (FeS) e calcopirite (CuFeS2) sono in grado di reagire ed incorporare il Hg(Q). Polymers with adsorbed finely dispersed metals in elemental form (h) such as gold, silver, zinc, aluminum, copper and other non-toxic metals capable of forming amalgam with IIg (0), are eg. obtained as per J Biomater Sci Polym Ed 2009, 20 (3): 311-24 or Carb Polymers 2006, 65: 430-34 or sold as susp. 3% on bio-polymer, denominated â € œNano Biosi 1 verâ €. Polymers with adsorbed finely dispemi (i) sulphides such as silver (AgS), sphalerite (ZnS), pyrite (FeS) and chalcopyrite (CuFeS2) are able to react and incorporate Hg (Q).
I polimeri compositi con associazione polimero-agente ossidante (j) sono ad es. il povidoneperossido dì idrogeno (PVP-H2O2) a favorire la conversione Hg(0)-> Hg<4>, in presenza di materiali accettori di quest’ultimo scelti nel gruppo da (a) a (g). Composite polymers with polymer-oxidizing agent association (j) are e.g. povidone peroxide of hydrogen (PVP-H2O2) to favor the conversion Hg (0) -> Hg <4>, in the presence of acceptor materials of the latter selected in the group from (a) to (g).
Tale materiale à ̈ disponibile come Gantrezâ„¢ da ISP (Wayne, NJ, USA) o producìbile in situ all’ato della preparazione della composizione, es, per spray-drying di polyvinylpyrrolidone (es. PVP K-30) con soluzione di H2O2 70% a 15-25 g of soluzione/minuto/kg PVP per circa 20 minuti, a dare un PVP contenente 18% di H2O2 e 6% di umidità . This material is available as Gantrezâ „¢ from ISP (Wayne, NJ, USA) or can be produced in situ when preparing the composition, e.g. by spray-drying polyvinylpyrrolidone (e.g. PVP K-30) with 70% H2O2 solution at 15-25 g of solution / minute / kg PVP for about 20 minutes, to give a PVP containing 18% H2O2 and 6% humidity.
La quantità dei polimeri nella composizione delia presente invenzione varia tra 50% e 0,005% in peso della composizione, preferibilmente tra 1% e 0,01% in peso della composizione, ancor più preferibilmente intorno allo 0,1% in peso della composizione. The amount of polymers in the composition of the present invention varies between 50% and 0.005% by weight of the composition, preferably between 1% and 0.01% by weight of the composition, even more preferably around 0.1% by weight of the composition.
L’uso di detti polimeri in forma semplice o associata in composizioni destinate alla somministrazione nel tratto orofaringeo e gastrointestinale consente la captazione e detossicazione di mercurio ed altri metalli pesanti da otturazioni o da fonti alimentari. The use of said polymers in simple or associated form in compositions intended for administration in the oropharyngeal and gastrointestinal tract allows the uptake and detoxification of mercury and other heavy metals from fillings or from food sources.
In una realizzazione inventiva un polimero a captazione simultanea di Hg(0) e Hg(II) scelto tra (a) e (d) e loro miscele sono utilizzati per la prevenzione 0 detossicazione da mercurio. In un’altra realizzazione inventiva un polimero a captazione di Hg(II) (e)-(g) à ̈ associato ad un polimero a captazione di Hg(Q) scelto tra (h) e (i). In un’altra realizzazione inventiva un polimero a captazione simultanea di Hg(0) e Hg(ll) (a)-(d) à ̈ associato ad un polimero a captazione di Hg(0) scelto tra (h) e (i) e/o ad un polimero a captazione di Hg(ll) scelto tra (e) e (g).In un’ulteriore realizzazione inventiva un polimero a captazione di Hg(II) scelto tra (e) e (g) à ̈ associato un polimero a conversione di Hg(0) in Hg(II) tipo (j). In an inventive embodiment a polymer with simultaneous uptake of Hg (0) and Hg (II) selected between (a) and (d) and their mixtures are used for the prevention or detoxification from mercury. In another inventive embodiment a Hg (II) (e) - (g) uptake polymer is associated with a Hg (Q) uptake polymer selected between (h) and (i). In another inventive embodiment a polymer with simultaneous Hg (0) and Hg (ll) (a) - (d) uptake is associated with a Hg (0) uptake polymer chosen between (h) and (i ) and / or to a Hg (II) uptake polymer chosen between (e) and (g). In a further inventive embodiment a Hg (II) uptake polymer selected between (e) and (g) à A polymer converting Hg (0) into Hg (II) type (j) is associated.
Preferibilmente la composizione della presente invenzione assumerà la forma di colluttorio, dentifricio, dentifricio liquido, gel, film, gel su film, granuli, paste da denti, polvere dentale, pasta profilattica, e gomma da masticare nelle varie presentazioni di confetteria dentale. Preferably the composition of the present invention will take the form of mouthwash, toothpaste, liquid toothpaste, gel, film, gel on film, granules, toothpaste, dental powder, prophy paste, and chewing gum in various dental confectionery presentations.
li Il termine “colluttorio†comprende composizioni orali non-ìngeribili liquide come soluzioni colluttorie idroalcoliche, spray ed altri prodotti da risciacquo. Il termine “dentifricio†comprende composizioni concepite per l igiene dentale come dentifricio mono- e multi-fase, dentifricio liquido o polvere, tavolette, creme e gel dentali. Î temine “gomma da masticare†comprende tavolette masticabili, losanghe ed altre modalità alla voce “chewing gum†. li The term "mouthwash" includes liquid non-ingestible oral compositions such as hydroalcoholic mouthwash solutions, sprays and other rinsing products. The term â € œtoothpasteâ € includes compositions designed for dental hygiene such as single- and multi-stage toothpaste, liquid or powder toothpaste, tablets, creams and dental gels. The term â € œchewing gumâ € includes chewable tablets, lozenges and other modalities under the heading â € œchewing gumâ €.
Altre forme di composizioni come gel, film, gel su film, granuli, pasta e polvere dentale, sono spalmabili e/o applicabili sui denti e/o mucosa orale direttamente o con supporto esterno. Le composizioni secondo V invenzione potranno contenere svariati ingredienti utilizzati nei preparati odonto-dentali ad es. agenti anti-carie, desensibilizzanti, viscosizzanti ed agenti reologici, diluenti, tensioattivi ed emulsionanti, modulatori di schiuma, modificatori di pH, abrasivi, umettanti, modificatori di gusto, dolcificanti, aromi, coloranti, conservanti, ecc. In una modalità applicativa, le composizioni ad uso odontostomatologico secondo l invenzione, ad esempio in forma di dentifricio, gomma da masticare, gel o collutorio, saranno utilizzate da 1 a 3 volte al giorno in soggetti portatori di otturazioni in amalgama o da operatori (dentisti e personale odontoiatrico), o almeno una volta al giorno, oppure una o due volte la settimana o al mese nel caso di un uso profilattico-preventivo in soggetti asintomatici. Il trattamento da condurre in ambito ambulatoriale o domiciliare potrà variare da qualche giorno a 6 mesi o 1 anno o oltre, ovvero per un periodo di tempo sufficiente alla scomparsa dei sintomi di intossicazione locale o sistemica come quelli descritti dì seguito. Other forms of compositions such as gels, films, gels on films, granules, pastes and dental powder, are spreadable and / or applicable on the teeth and / or oral mucosa directly or with external support. The compositions according to the invention may contain various ingredients used in the dental-dental preparations, e.g. anti-caries agents, desensitizers, viscosifiers and rheological agents, diluents, surfactants and emulsifiers, foam modulators, pH modifiers, abrasives, humectants, taste modifiers, sweeteners, flavors, dyes, preservatives, etc. In one application mode, the compositions for odontostomatological use according to the invention, for example in the form of toothpaste, chewing gum, gel or mouthwash, will be used 1 to 3 times a day in subjects with amalgam fillings or by operators (dentists and dental staff), or at least once a day, or once or twice a week or a month in the case of prophylactic-preventive use in asymptomatic subjects. The treatment to be carried out in an outpatient or home setting may vary from a few days to 6 months or 1 year or more, or for a period of time sufficient for the disappearance of the symptoms of local or systemic intoxication such as those described below.
Soggetti preferiti per l utilizzo delle composizioni odontostomatologiche secondo l invenzione sono portatori un numero elevato di otturazioni dentali in amalgama, ad esempio da 5 a 20 ed oltre, preferibilmente da 9 in su, sebbene anche soggetti con numero limitato di tali otturazioni (da 1 a 5) possano beneficiare di un uso saltuario a fini preventivi-detossicanti. Preferred subjects for the use of the odontostomatological compositions according to the invention are carriers of a large number of dental amalgam fillings, for example from 5 to 20 and more, preferably from 9 upwards, although also subjects with a limited number of such fillings (from 1 to 5) can benefit from occasional use for preventive-detoxifying purposes.
Altro soggetti particolarmente preferiti per Putilizzo di queste composizioni sono coloro ai quali sono state rimosse uno o più otturazioni e/o denti con otturazioni in amalgama, con modalità di somministrazione che segue o accompagna, ad es. con sciacqui, tale intervento. In un’ulteriore realizzazione inventiva le composizioni secondo l’invenzione consistono in mascherine imbevute, impregnate o imbibite con i materiali da (a) a (j). Tali dispositivi possono essere concepite come mascherine monouso ad es. dentisti o odontotecnici, sostituendo le pesanti maschere anti-mercurio ad es. prodotte da Mercury Safety Products Ltd. Soggetti preferiti per lutilìzzo delle mascherine odontoiatriche secondo Pinvenzione sono gli operatori odontoiatrici quali dentisti e personale dì supporto (odontotecnici). Other particularly preferred subjects for the use of these compositions are those from whom one or more fillings and / or teeth with amalgam fillings have been removed, with the following or accompanying method of administration, eg. with rinses, such intervention. In a further inventive embodiment, the compositions according to the invention consist of masks soaked, impregnated or soaked with the materials from (a) to (j). Such devices can be conceived as disposable masks eg. dentists or dental technicians, replacing the heavy anti-mercury masks eg. produced by Mercury Safety Products Ltd. Preferred subjects for the use of dental templates according to the invention are dental operators such as dentists and support staff (dental technicians).
Le composizioni possono inoltre essere concepite per la somministrazione per os in forma di bustine, di capsule di gelatine morbida o rigida, di compresse a rilascio rapido o ritardato, o in forma liquida per la detossicazione gastrointestinale, ad es. Remington: The Science and Practice of Pharmacy (20th ed.), ed. A.R. Gennaro, Lippincott Williams & Wilkins, 2000. Soggetti preferiti per l’utilizzo delle composizioni gastroenterologiche secondo l’invenzione sono portatori di otturazioni dentali in amalgama, operatori odontoiatrici e ad altri soggetti con intossicazione da mercurio come addetti ad impianti chimici, ecc. The compositions can also be designed for oral administration in the form of sachets, soft or hard gelatin capsules, fast or delayed release tablets, or in liquid form for gastrointestinal detoxification, e.g. Remington: The Science and Practice of Pharmacy (20th ed.), Ed. A.R. Gennaro, Lippincott Williams & Wilkins, 2000. Preferred subjects for the use of the gastroenterological compositions according to the invention are carriers of dental amalgam fillings, dental operators and other subjects with mercury poisoning such as chemical implant workers, etc.
Le composizioni sono utilizzate per trattare/pre venire i danni locali da mercurio come sindrome dalla bocca urente, leucoplachia orale, stomatite lichenoide, dermatite da contatto, orticaria, cheilite, stomatite, baboon syndrome, acrodinia, granulomatosi orofacetale, eczema ponfolitico, reazioni sarcoidi, prurito, eruzioni, osteonecrosi, cicatrizzazione ritardata/carente. Ulteriori vantaggi delle composizioni inventive riguardano la prevenzione o il trattamento di intossicazione sistemiche da mercurio con disturbi quali: disordini neuro-otologici, ipoacusiasordità , vertigini, acufeni, cefalea, insonnia, affaticamento, disordini emotivi, depressione, perdita di memoria, disfunzione delle ghiandole surrenali, alopecia, anoressia, malformazioni fetale, autismo, disfunzioni tiroidee e del sistema immunitario, insonnia, danni renali, formicolio o dolore agli arti, tremori, debolezza muscolare, salivazione eccessiva, colite. Gli esempi seguenti illustrano difatti alcune modalità esecutive dell' invenzione, non essendo intesi a limitarne gli scopi. The compositions are used to treat / prevent local mercury damage such as burning mouth syndrome, oral leukoplakia, lichenoid stomatitis, contact dermatitis, urticaria, cheilitis, stomatitis, baboon syndrome, acrodynia, orofacetal granulomatosis, ponfolytic eczema, sarcoid reactions, itching, rashes, osteonecrosis, delayed / deficient scarring. Further advantages of the inventive compositions relate to the prevention or treatment of systemic mercury poisoning with disorders such as: neuro-otological disorders, hypo-enthusiasm, dizziness, tinnitus, headache, insomnia, fatigue, emotional disorders, depression, memory loss, adrenal gland dysfunction , alopecia, anorexia, fetal malformations, autism, thyroid and immune system dysfunction, insomnia, kidney damage, tingling or pain in the limbs, tremors, muscle weakness, excessive salivation, colitis. In fact, the following examples illustrate some executive methods of the invention, not being intended to limit the purposes thereof.
ESEMPI EXAMPLES
Esempio 1 - Preparazione di gel e valutazione del potenziale detossicante Example 1 - Preparation of gel and evaluation of the detoxifying potential
(A) La resina Ambersep GT74 della Rohm and Haas-Dow à ̈ asciugata e macinata a dare una polvere fine con particelle comprese tra 5 e 20 Î1⁄4πι. Le polveri sono quindi trattate in corrente d’aria calda a 40°C per circa 4 ore, quindi un gel à ̈ ottenuto sospendendone 0,2 g in 100 mi d’acqua con 0,5 g di Carbopolâ„¢ Ultrez 10NF, infine neutralizzando a pH 6,5 con NaOH 5N. (B) Un tiomero idrocolloide-cìsteina viene preparato mediente reazione del copolimero Gantrezâ„¢ AN-119 con ì-cìsteina a dare il corrispondente tiomero come descritto in WO/1991/003521 con opportune modificazioni. In breve, una miscela di THF e DMSO (750 mi) posta in un reattore provvisto di agitatore, condensatore a riflusso e termometro à ̈ addizionata con 78,1 g (0,5 moli) di Gantrezâ„¢ AN-119 scaldando a 60°C per 1 ora sotto azoto. Quindi si aggiunge 1-cisteina (48,4 g, 0,4 moli) in porzioni con progressiva formazione di precipitato. L’agitazione à ̈ proseguita per altre 2 ore a 60°C, quindi si raffredda a 30°C ed il prodotto risultante à ̈ filtrato ed essicato sotto vuoto a dare circa 120 g di prodotto (resa 97%). L’analisi del prodotto previa idrolisi con HC1 0,1N e la spettrofotometria FT-IR confermano una conversione pari a circa il 75% delle funzioni diacidomaleiche in gruppi amidotiolici. Un gel di polimaleato-cisteìna parzialmente ossidata à ̈ ottenuto sospendendone una quota dì 02 g in 100 mi d’acqua e mantenendo la sospensione sotto forte agitazione areata per 30’. (C) Un gel di cheratina à ̈ ottenuto per sospensione di 0,2 g di cheratina cosmetica in 100 ml d’acqua con 0,5 g dì Carbopolâ„¢ Ultrez 10NF, neutralizzando a pH 6,5 con NaOH 5N. (A) Rohm and Haas-Dow Ambersep GT74 resin is dried and ground to a fine powder with particles ranging from 5 to 20 Î1⁄4Ï € ι. The powders are then treated in a stream of hot air at 40 ° C for about 4 hours, then a gel is obtained by suspending 0.2 g in 100 ml of water with 0.5 g of Carbopolâ „¢ Ultrez 10NF , finally neutralizing at pH 6.5 with 5N NaOH. (B) A hydrocolloid-cìsteine thiomer is prepared by reaction of the Gantrezâ „¢ AN-119 copolymer with ì-cìsteine to give the corresponding thiomer as described in WO / 1991/003521 with suitable modifications. Briefly, a mixture of THF and DMSO (750 ml) placed in a reactor equipped with stirrer, reflux condenser and thermometer is added with 78.1 g (0.5 mol) of Gantrezâ „¢ AN-119 heating to 60 ° C for 1 hour under nitrogen. Then 1-cysteine (48.4 g, 0.4 moles) is added in portions with progressive precipitate formation. The stirring is continued for another 2 hours at 60 ° C, then it is cooled to 30 ° C and the resulting product is filtered and dried under vacuum to give about 120 g of product (yield 97%). Analysis of the product after hydrolysis with 0.1N HC1 and FT-IR spectrophotometry confirm a conversion of approximately 75% of the diacidomal functions into amidothiol groups. A partially oxidized polimaleate-cysteine gel is obtained by suspending a share of 02 g in 100 ml of water and keeping the suspension under strong aerated agitation for 30â € ™. (C) A keratin gel is obtained by suspending 0.2 g of cosmetic keratin in 100 ml of water with 0.5 g of Carbopolâ „¢ Ultrez 10NF, neutralizing to pH 6.5 with 5N NaOH.
(D) Una melanina ibrida tipo Phytomelanìnâ„¢ à ̈ ottenuta sciogliendo in un litro di NaOH IN 46 g di 1-Dopa, 15 g di rutina triidrata, 17 g di acido gallico monoidrato, 22 g di OPC da vinacciolo sotto gorgolgiamento d’aria a 37° per 24 ore. Su una porzione di 10 mi diluita con 90 mi di acqua e acido citrico fino a pH 8, poi 0,5 g di Carbopolâ„¢ a dare un gel scuro . (D) A hybrid melanin type Phytomelanìnâ „¢ is obtained by dissolving in a liter of NaOH IN 46 g of 1-Dopa, 15 g of rutin trihydrate, 17 g of gallic acid monohydrate, 22 g of OPC from grapeseed under bubbling of air at 37 ° for 24 hours. On a portion of 10 ml diluted with 90 ml of water and citric acid to pH 8, then 0.5 g of Carbopolâ „¢ to give a dark gel.
(E) Un gel di chitosano à ̈ ottenuto sciogliendo 2 g di Chitopharmâ„¢ L (Cognis) in 100 mi di una soluzione acquosa di 1 g di acido acetico e 3 g di glicerolo sotto agitazione continua per 2 ore. La soluzione giallina à ̈ poi neutralizzata a pH 7 con NaOH 5N a dare un gel trasparente. (F) Un gel dì (poli)maleato tipo MVE/MA à ̈ ottenuto sospendendo 4 g dì Gantrexâ„¢ AN-119 tn 100 ml di acqua aggiustata a pH 7,5 con soda, lasciando sotto agitazione per 30’. (E) A chitosan gel is obtained by dissolving 2 g of Chitopharmâ „¢ L (Cognis) in 100 ml of an aqueous solution of 1 g of acetic acid and 3 g of glycerol under continuous stirring for 2 hours. The yellowish solution is then neutralized to pH 7 with 5N NaOH to give a transparent gel. (F) A gel of (poly) maleate type MVE / MA is obtained by suspending 4 g of Gantrexâ „¢ AN-119 tn 100 ml of water adjusted to pH 7.5 with soda, leaving under stirring for 30â € ™ .
(G) Un composito inorganico tio-attivato à ̈ preparato facendo adsorbire il dimetil solfossido su allumina neutra con la modalità descritta da Soliman e coll. (Talanta 2006; 69(l}:55-60), quindi un gel à ̈ ottenuto sospendendone 0,4 g in 100 mi di gel Carbopolâ„¢ portato a pH 6,5. (H) Un gel di particelle d’argento à ̈ ottenuto sospendendo diluendo 3 mi di Nano Biosìlver (www.nanobiosilver.com) venduto ondine come sosp. 3% su biopolimero non specificato in 97 mi d’acqua, gelìiicando con 0,4 g di Carbopolâ„¢ neutralizzato a pH 6,5 con NaOH 5N. (I) Un gel di ZnS à ̈ ottenibile mediante precipitazione di 0,2 g di sfalerite sintetica ottenuta da Sigma- Aldrich (cat, N. 244627) adsorbita e gelifìcata in 100 mi di gel di Carbopolâ„¢. (G) A thio-activated inorganic composite is prepared by adsorbing dimethyl sulfoxide on neutral alumina in the manner described by Soliman et al. (Talanta 2006; 69 (l}: 55-60), therefore a gel is obtained by suspending 0.4 g in 100 ml of Carbopolâ „¢ gel brought to pH 6.5. (H) A gel of particles of silver is obtained by diluting 3 ml of Nano Biosìlver (www.nanobiosilver.com) sold online as a 3% suspension on unspecified biopolymer in 97 ml of water, freezing with 0.4 g of Carbopolâ " ¢ neutralized to pH 6.5 with 5N NaOH. (I) A ZnS gel can be obtained by precipitation of 0.2 g of synthetic sphalerite obtained by Sigma-Aldrich (cat, N. 244627) adsorbed and gelified in 100 ml of Carbopolâ „¢ gel.
(J) Un gel fluido di povidone-perossido di idrogeno à ̈ ottenuto aggiungendo ad una sospensione di 8 g di PVP K-30 una quantità di 2 g di H2<3⁄4 70% ed agitando per circa 20’, Misurazione della capacità di captazione del mercurio elementare e ionico (J) A fluid gel of povidone-hydrogen peroxide is obtained by adding to a suspension of 8 g of PVP K-30 an amount of 2 g of H2 <3⁄4 70% and stirring for about 20â € ™. ability to capture elemental and ionic mercury
La frazione complessiva di Hg(0) e Hg(II) catturato dai gel contenenti i polimeri secondo l’invenzione à ̈ valutabile in maniera veloce ed affidabile con lo strumento DMA-80 Direct Mercury Analyzer (Milestone Srl, Sorisoie (BG), Italia). The total fraction of Hg (0) and Hg (II) captured by the gels containing the polymers according to the invention can be evaluated quickly and reliably with the DMA-80 Direct Mercury Analyzer (Milestone Srl, Sorisoie (BG), Italy).
Il metodo à ̈ citato come riferimento in U.S. EPA Method 7473, U.S. EPA Draft Method 30 B e ASTM Method D6722-01 in quanto non richiede preparazione del campione e fornisce risultati affidabili sul contenuto totale di mercurio con range dinamico di 0.0015 ng - 1000 ng. In pratica la verifica à ̈ conducìbile in vitro su denti con otturazione in amalgama estratti da dentisti nell’attività odontoiatrica, o direttamente in vivo nel cavo boccale di pazienti con un certo numero di otturazione in amalgama. The method is cited as a reference in U.S. EPA Method 7473, U.S. EPA Draft Method 30 B and ASTM Method D6722-01 as it does not require sample preparation and provides reliable results on the total mercury content with a dynamic range of 0.0015 ng - 1000 ng. In practice, the verification can be carried out in vitro on teeth with amalgam fillings extracted by dentists in the dental practice, or directly in vivo in the mouth cavity of patients with a certain number of amalgam fillings.
Una valutazione di efficacia eseguita su gel preparati come sopra, calcolati al netto del contenuto iniziale di Hg de! campione pre-trattamento, può fornire risultati come da Tabella I. TABELLA 1 An efficacy evaluation performed on gels prepared as above, calculated net of the initial content of Hg de! pre-treatment sample, can provide results as per Table I. TABLE 1
Polimero in sospensione gelificata Conc, (w/w) Range di Hg tot captato (A) Gel dì resina Ambersepâ„¢ GT74 parz. oss, 0,2% 30- 350 ng Polymer in gelled suspension Conc, (w / w) Range of Hg tot captured (A) Ambersepâ „¢ GT74 part. oss, 0.2% 30-350 ng
(B) Gel di tiomero polimaleato-cisteina parz. oss.0,2% 20 - 230 ng (B) Polimaleate-cysteine thiomer gel part. obs. 0.2% 20 - 230 ng
(E) Gel di chitosano Chitopharmâ„¢ L 2,0% 0,5 - 30 ng (E) Chitopharmâ „¢ Chitosan gel 2.0% 0.5 - 30 ng
(F) Gel di polimaleato Gantrezâ„¢ 4,0% 1.0 -45 ng (F) Gantrezâ „¢ 4.0% 1.0 -45 ng polymaleate gel
(G) Gel di allumina-DMSO 0,4% 1.0-25 ng (G) Alumina-DMSO gel 0.4% 1.0-25 ng
(H) Gel di Ag° colloidale 0, 1 % 10 - ISO ng (H) Colloidal Ag ° gel 0.1% 10 - ISO ng
(J) Gel di PVP-H2O2. _ _ 10% 2 -75 ng (J) PVP-H2O2 gel. _ _ 10% 2 -75 ng
La massima efficienza verrà fornita dai tiolici polimeri a doppia funzionalità (A)-(C), seguita dal polimero-metallo specifico per la captazione di Hg(0) tipo (H), mentre i polimeri a capacità chelante nei confronti del Hg(II) tipo (E)-(G) risultano meno efficaci in funzione di una bassa presenza della specie mercuriale ionica (Hg<++>) e metilmercurio nel cavo orale. La sperimentazione, opportunamente convalidata, condurrà alPevidenza che l’efficace detossicazione può essere realizzata con polimeri a captazione simultanea di mercurio ionico e metallico e/o con combinazioni di polimeri a captazione specifica di una delle due specie. The maximum efficiency will be provided by thiol dual-function polymers (A) - (C), followed by the specific metal-polymer for the uptake of Hg (0) type (H), while the polymers with chelating capacity towards Hg (II ) type (E) - (G) are less effective due to the low presence of the ionic mercurial species (Hg <++>) and methylmercury in the oral cavity. The experimentation, duly validated, will lead to the evidence that effective detoxification can be achieved with polymers with simultaneous uptake of ionic and metallic mercury and / or with combinations of polymers with specific uptake of one of the two species.
Esempio 2 - Collutorio Example 2 - Mouthwash
Ingredienti Quantità Ingredients Quantity
Polimeri secondo l’invenzione<(1)>q.s. Polymers according to the invention <(1)> q.s.
Glicerolo 5,0 g Glycerol 5.0 g
Sucralosio 0,1 g Sucralose 0.1 g
Aromi 0,15 g Flavors 0.15 g
Alcol etilico 5,0 g Ethyl alcohol 5.0 g
Alcol benzilico 0,5 g Benzyl alcohol 0.5 g
Acqua demineralizzata_ q.b. a 100 g Demineralized water_ q.s. to 100 g
- Tiomero polimaleato-cisteina parz. oss. 0,2 g - Thiomer polymaleate-cysteine part. obs. 0.2 g
- Cheratina cosmetica naturale 0,2 g - Natural cosmetic keratin 0.2 g
- Chitosano Chitopharmâ„¢ L 2,0 g Copolimero maleìco Gantrez 2 g - Chitosan Chitopharmâ „¢ L 2,0 g Maleico Gantrez copolymer 2 g
- Polimaleato Gantrezâ„¢ 2,0 g Ag° colloidale 0,1 g - Polimaleate Gantrezâ „¢ 2.0 g Colloidal Ag ° 0.1 g
- Polimaleato Gantrezâ„¢ 2,0 g PVP-H2O24,0 g - Polimaleate Gantrezâ „¢ 2.0 g PVP-H2O24.0 g
Esempio 3 - Gomma da masticare Example 3 - Chewing gum
Ingredienti_ Quantità Ingredients_ Quantity
Polimeri secondo l invenzione q.s. Polymers according to the invention q.s.
Aroma limone 0,5 g Lemon flavor 0.5 g
Sucralosio 0,3 g Sucralose 0.3 g
Colore giallo annatto (E160b) 0,05 g Annatto yellow color (E160b) 0.05 g
Colorante azzurro (E 133) sol. 0, 1 % 0, 1 g Blue dye (E 133) sol. 0.1% 0.1 g
Acido citrico 1,0 g Citric acid 1.0 g
Talco 1,0 g Talc 1.0 g
Magnesio stearato 5,0 g Magnesium stearate 5.0 g
Silice colloidale 1 ,0 g Colloidal silica 1.0 g
Pharmagumâ„¢ M _ q.b. a 100 g Pharmagumâ „¢ M _ q.b. to 100 g
- Resina resina Ambersepâ„¢ GT74 parz. oss. micronizzata 0,1 g - Ambersepâ „¢ GT74 resin resin parz. obs. micronized 0.1 g
- Resina resina Ambersepâ„¢ GT74 parz. oss. 0,05 g allumina-DMSO 0,2 g - Ambersepâ „¢ GT74 resin resin parz. obs. 0.05 g alumina-DMSO 0.2 g
- Chitosano Chitopharmâ„¢ L 1 g allumina-DMSQ 0,4 g Cheratina cosmetica 0,1 g - Phytomelaninâ„¢ 0,15 g (sostituisce i coloranti in formula) - Chitosan Chitopharmâ „¢ L 1 g alumina-DMSQ 0.4 g Cosmetic keratin 0.1 g - Phytomelaninâ„ ¢ 0.15 g (replaces the dyes in the formula)
Esempio 4 - Dentifricio Example 4 - Toothpaste
Ingredienti_ Quantità Ingredients_ Quantity
Polimeri secondo l’invenzione q.s. Polymers according to the invention q.s.
Glicerina 5,0 g Glycerin 5.0 g
Propilenglicole 2,5 g Propylene glycol 2.5 g
Sodio lauril solfato 1 ,7 g Sodium lauryl sulfate 1, 7 g
Macrogol 1600 1,0 g Macrogol 1600 1.0 g
Xilitolo 1 ,0 g Xylitol 1.0 g
Aromi 0,9 g Flavors 0.9 g
Sodio carbossimetil cellulosa 0,8 g Sodium carboxymethyl cellulose 0.8 g
Saccarina sodica 0,2 g Sodium saccharin 0.2 g
Sodio fosfato 0,2 g Sodium phosphate 0.2 g
Colorante azzurro (E 133) sol. 0, 1 % 0,1 g Blue dye (E 133) sol. 0.1% 0.1 g
Parabenì 0,2 g Parabenì 0.2 g
Acqua 20 g Water 20 g
Sciroppo di sorbitolo (70%) _ q.b, a 100 g Sorbitol syrup (70%) _ q.b, 100 g
- Resina resina Ambersepâ„¢ GT74 parz. oss, micronizzata 0,1 g - Ambersepâ „¢ GT74 resin resin parz. oss, micronized 0.1 g
- Tiomero polimaleato-cisteina parz. oss. 0,1 g, - Thiomer polymaleate-cysteine part. obs. 0.1 g,
- Tiomero polimaleato-cisteina parz. oss. 0,05 g allumina-DMSO 0,4 g - Thiomer polymaleate-cysteine part. obs. 0.05 g alumina-DMSO 0.4 g
- Chitosano Chitopharmâ„¢ L 1 ,5 g PVP-H2O24,0 g - Chitosan Chitopharmâ „¢ L 1, 5 g PVP-H2O 24,0 g
Esempio 5 - Mascherine protettive per operatori dentistici Example 5 - Protective masks for dental operators
Mascherine con elastici del tipo Ecomask Ondaâ„¢ (Kumapan, Online) sono impregnate con 10 mi di una soluzione contenente 0,05% di un tiomero tipo polimaleato-cisteina parzialmente ossidato spruzzata manualmente con un comune erogatore spray a pompa, in alternativa si possono utilizzare sospensioni di materiali puri o combinazioni come da esempi precedenti. Masks with elastics of the Ecomask Ondaâ „¢ type (Kumapan, Online) are impregnated with 10 ml of a solution containing 0.05% of a partially oxidized polymaleate-cysteine-type thiomer sprayed manually with a common pump spray, alternatively use suspensions of pure materials or combinations as per previous examples.
Esempio 6 - Capsule Example 6 - Capsules
Ingredienti Quantità (per capsula) Ingredients Quantity (per capsule)
Polimeri secondo l’invenzione<<4)>q.s. Polymers according to the invention << 4)> q.s.
Cellulosa {microcristallina) 50 mg Cellulose {microcrystalline) 50 mg
Silice colloidale 10 mg Colloidal silica 10 mg
PVP K 30 0.5 mg PVP K 30 0.5 mg
Etanolo 95° Q.S. per granulazione Ethanol 95 ° Q.S. for granulation
(4) - Resina resina Ambersepâ„¢ GT74 parz. oss. micronizzata 15 mg/capsula (4) - Ambersepâ „¢ GT74 resin resin parz. obs. micronized 15 mg / capsule
- Tiomero polimaleato-cisteina parz. oss. 10 mg/capsula - Thiomer polymaleate-cysteine part. obs. 10 mg / capsule
Le composizioni somministrate per 0$ in soggetti intossicati da mercurio sono monitorabili con l' analisi del campione pilifero, es. Doctors’ Data Ine. (Chicago, IL, USA. The compositions administered for $ 0 in mercury intoxicated subjects can be monitored with the analysis of the hair sample, eg. Doctorsâ € ™ Data Ine. (Chicago, IL, USA.
Claims (1)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI2010A000196A IT1398299B1 (en) | 2010-02-10 | 2010-02-10 | POLYMERS AND COMPOSITIONS FOR THE PREVENTION OR TREATMENT OF MUCOSAL DETOXATION FROM ELEMENTARY AND BIVALENT MERCURY |
PCT/IB2010/003066 WO2011067653A1 (en) | 2009-12-04 | 2010-11-30 | Oral compositions for use in the mercury intoxication from dental amalgam |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI2010A000196A IT1398299B1 (en) | 2010-02-10 | 2010-02-10 | POLYMERS AND COMPOSITIONS FOR THE PREVENTION OR TREATMENT OF MUCOSAL DETOXATION FROM ELEMENTARY AND BIVALENT MERCURY |
Publications (2)
Publication Number | Publication Date |
---|---|
ITMI20100196A1 true ITMI20100196A1 (en) | 2011-08-11 |
IT1398299B1 IT1398299B1 (en) | 2013-02-22 |
Family
ID=42313716
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ITMI2010A000196A IT1398299B1 (en) | 2009-12-04 | 2010-02-10 | POLYMERS AND COMPOSITIONS FOR THE PREVENTION OR TREATMENT OF MUCOSAL DETOXATION FROM ELEMENTARY AND BIVALENT MERCURY |
Country Status (1)
Country | Link |
---|---|
IT (1) | IT1398299B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP4197520A1 (en) * | 2021-12-15 | 2023-06-21 | Kao Germany GmbH | An aqueous composition for hair |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4141888A (en) * | 1977-03-07 | 1979-02-27 | Sekisui Kagaku Kogyo Kabushiki Kaisha | Process for producing reduced keratinous substances using urea or thiourea |
WO1997019670A1 (en) * | 1995-11-28 | 1997-06-05 | Jan Hedner | Method and composition for removal of mercury released from amalgam in the oral cavity |
US6013246A (en) * | 1994-03-02 | 2000-01-11 | Ctc Medical Ab | Preparation for inhibiting the release of mercury and for rendering mercury released from amalgam fillings harmless |
WO2001030707A1 (en) * | 1999-10-28 | 2001-05-03 | Solmetex, Inc. | Device and method for treating dental waste streams |
EP1348417A1 (en) * | 2002-03-28 | 2003-10-01 | Hofmann, Andreas | Mercury complexing substance for dental use |
-
2010
- 2010-02-10 IT ITMI2010A000196A patent/IT1398299B1/en active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4141888A (en) * | 1977-03-07 | 1979-02-27 | Sekisui Kagaku Kogyo Kabushiki Kaisha | Process for producing reduced keratinous substances using urea or thiourea |
US6013246A (en) * | 1994-03-02 | 2000-01-11 | Ctc Medical Ab | Preparation for inhibiting the release of mercury and for rendering mercury released from amalgam fillings harmless |
WO1997019670A1 (en) * | 1995-11-28 | 1997-06-05 | Jan Hedner | Method and composition for removal of mercury released from amalgam in the oral cavity |
WO2001030707A1 (en) * | 1999-10-28 | 2001-05-03 | Solmetex, Inc. | Device and method for treating dental waste streams |
EP1348417A1 (en) * | 2002-03-28 | 2003-10-01 | Hofmann, Andreas | Mercury complexing substance for dental use |
Non-Patent Citations (1)
Title |
---|
MAGOS L ET AL: "The effect of oral doses of a polythiol resin on the excretion of methylmercury in mice treated with cysteine, D-penicillamine or phenobarbitone", CHEMICO-BIOLOGICAL INTERACTIONS, ELSEVIER SCIENCE IRLAND, IR LNKD- DOI:10.1016/0009-2797(76)90111-3, vol. 14, no. 3-4, 1 August 1976 (1976-08-01), pages 325 - 335, XP023756134, ISSN: 0009-2797, [retrieved on 19760801] * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP4197520A1 (en) * | 2021-12-15 | 2023-06-21 | Kao Germany GmbH | An aqueous composition for hair |
WO2023110582A1 (en) * | 2021-12-15 | 2023-06-22 | Kao Germany Gmbh | An aqueous composition for hair |
Also Published As
Publication number | Publication date |
---|---|
IT1398299B1 (en) | 2013-02-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Riccio et al. | Stober synthesis of nitric oxide-releasing S-nitrosothiol-modified silica particles | |
US20140056976A1 (en) | Methods and compositions for heavy metal removal and for oral delivery of desirable agents | |
US8222239B2 (en) | Bridged polycyclic compound based compositions for the inhibition and amelioration of disease | |
EP2316430B8 (en) | Controlled release pharmaceutical compositions comprising a fumaric acid ester | |
US8575218B2 (en) | Thiol-containing compounds for the removal of elements from tissues and formulations therefor | |
CA2867439C (en) | Topically administered strontium-containing complexes for treating pain, pruritis and inflammation | |
RO120122B1 (en) | Medical composition and use thereof as medicine in topical barrier formulation, a uv-radiation absorbing formulation or an antiviral, antifungal or aniinflammatory formulation | |
BR9913178A (en) | Oral liquid mucoadhesive compositions | |
BR9913148A (en) | Oral liquid mucoadhesive compositions | |
DK1411900T4 (en) | Pharmaceutical compositions for the coordinated release of NSAIDs | |
JPWO2019211960A1 (en) | Method for Producing Composite Composition for Hydrogen Generation and Method for Producing Hydrogen | |
JP3595797B2 (en) | Sulfur adsorbent for reducing bad breath of onion or garlic | |
TR200100629T2 (en) | Oral compositions that adhere to mucous membranes containing gastrointestinal active substances | |
EP2234626A1 (en) | Method and means for producing bronchorelaxation | |
KR20140070758A (en) | Diseases treatmenter in mouth included calcium ion extracted from shell | |
ATE407690T1 (en) | TOPICAL PHARMACEUTICAL COMPOSITIONS CONTAINING ACTIVE NATURAL INGREDIENTS FOR PREVENTING AND TREATING MUCOSAL INFLAMMATORY PROCESSES | |
WO2007075255B1 (en) | Mastic gum composition for use as a dietary supplement in humans and animals | |
ITMI20100196A1 (en) | POLYMERS AND COMPOSITIONS FOR THE PREVENTION OR TREATMENT OF MUCOSAL DETOXATION FROM ELEMENTARY AND BIVALENT MERCURY | |
WO2011131203A2 (en) | A solid pharmaceutical composition for neutralizing stomach acid | |
EP1046410A2 (en) | Calcium and magnesium containing phosphate binding agent for the treatment of hyperphosphatemia | |
US11213505B2 (en) | Product based on iron bis-glycinate chelate and alginic acid and/or water-soluble salts thereof, formulations thereof, and pharmaceutical uses thereof | |
RU2281957C1 (en) | Water-soluble sodium-, calcium-, iron-polygalactouronate stimulating hemopoiesis | |
RU2548505C1 (en) | Method of treating chronic apical periodontitis | |
RU2784169C1 (en) | Method of increasing the resistance of the body to the harmful effects of a toxic combination polluting the workspace air and the surrounding atmosphere with relation to the activities of blister copper manufacture | |
RU2777203C1 (en) | Method for removing salts of heavy metals from the body |